The administration of specific mAbs to deplete individual T-cell subsets did not impact the non-depleted immune cell populations (CD4+, CD8+, or WC1+ γδ T cells or CD21+ cells), with the observed lymphopenia occurring after this depletion window of −2 dpi to 2 dpi. This evidence concerns the gene CR2 and lymphopenia.